The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase 3, multicenter, double-blind, placebo-controlled trial of lenvatinib (E7080) in patients with 131I-refractory differentiated thyroid cancer (SELECT).
Martin Schlumberger
Consultant or Advisory Role - AstraZeneca; Bayer; Eisai; Genzyme/Sanofi
Honoraria - AstraZeneca; Bayer; Eisai; Genzyme/Sanofi; SOBI
Research Funding - AstraZeneca; Bayer; Eisai; Genzyme/Sanofi
Makoto Tahara
Consultant or Advisory Role - Eisai; Merck Serono
Honoraria - Bristol-Myers Squibb; Merck Serono
Research Funding - Boehringer Ingelheim; Eisai
Lori J. Wirth
No relevant relationships to disclose
Bruce Robinson
Consultant or Advisory Role - AstraZeneca; Bayer; Eisai
Honoraria - AstraZeneca; Bayer; Eisai
Marcia S. Brose
Consultant or Advisory Role - Eisai
Research Funding - Eisai
Rossella Elisei
Consultant or Advisory Role - AstraZeneca; Bayer; Genzyme
Honoraria - AstraZeneca; Bayer; Genzyme
Corina E. Dutcus
Employment or Leadership Position - Eisai
BegoƱa de las Heras
Employment or Leadership Position - Eisai
Junming Zhu
Employment or Leadership Position - Eisai
Mouhammed Amir Habra
No relevant relationships to disclose
Kate Newbold
No relevant relationships to disclose
Manisha H. Shah
Consultant or Advisory Role - Exelixis
Research Funding - Bayer; Eisai; Exelixis
Ana O. Hoff
Research Funding - Eisai
Andrew G Gianoukakis
Research Funding - Eisai
Naomi Kiyota
Honoraria - Eisai
Research Funding - Eisai
Matthew Hiram Taylor
No relevant relationships to disclose
Sung-Bae Kim
Consultant or Advisory Role - Novartis (U)
Research Funding - II Dong Pharmaceuticals; Novartis
Monika K Krzyzanowska
Consultant or Advisory Role - Bayer/Onyx (U)
Honoraria - AstraZeneca; Novartis; Sanofi
Research Funding - AstraZeneca; Eisai; Exelixis; Novartis
Steven I. Sherman
Consultant or Advisory Role - Amgen; AstraZeneca; Bayer; Eisai; Exelixis; Pfizer; Roche
Honoraria - Exelixis; Onyx
Research Funding - Amgen
Other Remuneration - Exelixis